Arcangelo Liso
Arcangelo Liso
University of Perugia, Italy
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype
B Falini, C Mecucci, E Tiacci, M Alcalay, R Rosati, L Pasqualucci, ...
New England Journal of Medicine 352 (3), 254-266, 2005
BRAF mutations in hairy-cell leukemia
E Tiacci, V Trifonov, G Schiavoni, A Holmes, W Kern, MP Martelli, ...
New England Journal of Medicine 364 (24), 2305-2315, 2011
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
R Garzon, M Garofalo, MP Martelli, R Briesewitz, L Wang, ...
Proceedings of the National Academy of Sciences 105 (10), 3945-3950, 2008
Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma—a feasibility study
VL Reichardt, CY Okada, A Liso, CJ Benike, KE Stockerl-Goldstein, ...
Blood, The Journal of the American Society of Hematology 93 (7), 2411-2419, 1999
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML
B Falini, N Bolli, J Shan, MP Martelli, A Liso, A Pucciarini, B Bigerna, ...
Blood 107 (11), 4514-4523, 2006
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?
B Falini, MP Martelli, N Bolli, P Sportoletti, A Liso, E Tiacci, T Haferlach
Blood, The Journal of the American Society of Hematology 117 (4), 1109-1120, 2011
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications
B Falini, N Bolli, A Liso, MP Martelli, R Mannucci, S Pileri, I Nicoletti
Leukemia 23 (10), 1731-1743, 2009
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype
V Grossmann, E Tiacci, AB Holmes, A Kohlmann, MP Martelli, W Kern, ...
Blood, The Journal of the American Society of Hematology 118 (23), 6153-6163, 2011
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias
B Falini, I Nicoletti, N Bolli, MP Martelli, A Liso, P Gorello, F Mandelli, ...
haematologica 92 (4), 519-532, 2007
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)
B Falini, E Tiacci, A Liso, K Basso, E Sabattini, R Pacini, R Foa, A Pulsoni, ...
The Lancet 363 (9424), 1869-1871, 2004
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors
K Basso, A Liso, E Tiacci, R Benedetti, A Pulsoni, R Foa, F Di Raimondo, ...
The Journal of experimental medicine 199 (1), 59-68, 2004
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
B Falini, MP Martelli, N Bolli, R Bonasso, E Ghia, MT Pallotta, D Diverio, ...
Blood 108 (6), 1999-2005, 2006
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin
H Quentmeier, MP Martelli, WG Dirks, N Bolli, A Liso, RAF MacLeod, ...
Leukemia 19 (10), 1760-1767, 2005
Abnormal pattern of lymphocyte subpopulations in the endometrium of infertile women with chronic endometritis
M Matteo, E Cicinelli, P Greco, F Massenzio, D Baldini, T Falagario, ...
American journal of reproductive immunology 61 (5), 322-329, 2009
T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction
S Colucci, G Brunetti, R Rizzi, A Zonno, G Mori, G Colaianni, D Del Prete, ...
Blood 104 (12), 3722-3730, 2004
Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma
A Liso, KE Stockerl-Goldstein, S Auffermann-Gretzinger, CJ Benike, ...
Biology of Blood and Marrow Transplantation 6 (6), 621-627, 2000
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML)
B Falini, L Flenghi, M Fagioli, FL Coco, I Cordone, D Diverio, ...
Blood, The Journal of the American Society of Hematology 90 (10), 4046-4053, 1997
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
B Falini, D Lenze, R Hasserjian, S Coupland, D Jaehne, C Soupir, A Liso, ...
Leukemia 21 (7), 1566-1570, 2007
FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience
D Pastore, G Specchia, P Carluccio, A Liso, A Mestice, R Rizzi, G Greco, ...
Annals of hematology 82, 231-235, 2003
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice
MP Martelli, V Pettirossi, C Thiede, E Bonifacio, F Mezzasoma, D Cecchini, ...
Blood, The Journal of the American Society of Hematology 116 (19), 3907-3922, 2010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20